Roivant Sciences (FRA:87S) Change In Inventory : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Roivant Sciences Change In Inventory?

Roivant Sciences's change in inventory for the quarter that ended in Mar. 2025 was €0.00 Mil. It means Roivant Sciences's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Roivant Sciences's change in inventory for the fiscal year that ended in Mar. 2025 was €0.00 Mil. It means Roivant Sciences's inventory stayed the same from Mar. 2024 to Mar. 2025 .

Roivant Sciences's Total Inventories for the quarter that ended in Mar. 2025 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Roivant Sciences's Days Inventory for the quarter that ended in Mar. 2025 was 0.00.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Roivant Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.00.

Roivant Sciences Change In Inventory Historical Data

The historical data trend for Roivant Sciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roivant Sciences Change In Inventory Chart

Roivant Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Inventory

Roivant Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Roivant Sciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Roivant Sciences (FRA:87S) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Roivant Sciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0.189	*	365 / 4
	=	0.00

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Roivant Sciences's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.189	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Roivant Sciences's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	7.002
	=	0.00

Roivant Sciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of Roivant Sciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Roivant Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Roivant Sciences Ltd (FRA:87S) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ROIV:USA 87S:Germany

Address

50 Broadway, 7th Floor, London, GBR, SW1H 0BD

Website

https://www.roivant.com

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Roivant Sciences Headlines

No Headlines